For instance, the oncogenic EML4–ALK fusion, resulting from the inversion of chromosome 2, on which both genes are located, was described in anaplastic lymphoma, and later in patients with non-small cell lung cancer. This evidence concerns the gene ALK and non-small cell lung carcinoma.